The association between left ventricle diastolic dysfunction and endothelial dysfunction and the results of stress myocardial SPECT in asymptomatic patients with type 2 diabetes

Journal of International Medical Research

Volumn 33, Issue 5, 2005, Pages 473-482

  Charvát, Jiri ^a   Michalova, K ^a   Chlumsky J ^a   Valenta, Z ^b   Kvapil, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF COMPUTER SCIENCE   (Czech Republic)

Author keywords

Coronary heart disease; Left ventricular diastolic dysfunction; Left ventricular hypertrophy; Stress myocardial SPECT; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; DETERIORATION; ENDOTHELIUM LESION; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; SYMPTOMATOLOGY;

EID: 25844463566     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300501     Document Type: Article

References (30)

1. Alberti KG, Zimmet PZ, Defronzo RA: International Textbook of Diabetes Mellitus. Chichester: John Wiley & Sons Ltd, 1978.
2. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979; 241: 2035-2038.
3. Stamler J, Vaccaro O, Neaten JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
4. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, et al: Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assesment by exercise thallium scintigraphy. Ann Intern Med 1988; 108: 170-175.
5. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al: Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002; 105: 32-40.
6. Torremocha F, Hadjadj S, Carrie F, Rosenberg T, Herpin D, Marechaud R: Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients. Diabetes Metab 2001; 27: 49-57.
7. Weiner DA, Ryan TJ, Parsons L, Fisher LD, Chaitman BR, Sheffield LT, et al: Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) Registry. Am J Cardiol 1991; 68: 729-734.
8. American Diabetes Association: Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998; 21: 1551-1559.
9. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V: Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999; 22: 1396-1400.
10. Milan Study of Atherosclerosis and Diabetes (MiSAD) Group: Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol 1997; 79: 134-139.
11. Bacci S, Villella M, Villella A, Langialonga T, Grilli M, Rauseo A, et al: Screening of silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol 2002; 147: 649-654.
12. De Lorenzo A, Lima RS, Siquiera-Filho AG, Pantoja MR: Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002; 90: 827-832.
13. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al: Exercise myocardial perfusion SPECT in patients without known coronary artery disease. incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905-914.
14. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004; 27: 1954-1961.
15. Schiller NB: Two-dimensional echocardiographic determination of left ventricular volume, systolic function and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991; 84 (Suppl 3): I280-I287.
16. Rydberg E, Willenheimer R, Erhardt L: The prevalence of impaired left ventricular diastolic filling is related to the extent of coronary atherosclerosis in patients with stable coronary artery disease. Coron Artery Dis 2002; 13: 1-7.
17. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Rand WM, Udelson JE, et al: Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 2001; 38: 1843-1849.
18. Papaioannou GI, Seip RL, Grey NJ, Katten D, Taylor A, Inzucchi SE, et al: Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics - brachial artery reactivity study). Am J Cardiol 2004; 94: 294-299.
19. Berman DS, Hayes SW, Germano G: Assessment of myocardial perfusion and viability with technecium-99m perfusion agents. In: Cardiac SPECT Imaging (De Puey EG, Garcia EV, Berman DS, eds). Philadelphia: Lippincott, Williams and Wilkins, 2001; pp179-184.
20. Maddahi J, Berman DS: Detection, evaluation and risk stratification of coronary artery disease by thalium-201 myocardial perfusion scintigraphy. Pharmacologic stress testing with dipyridamole. In: Cardiac SPECT Imaging (De Puey EG, Garcia EV, Berman DS, eds). Philadelphia: Lippincott, Williams and Wilkins, 2001; pp159-160.
21. Cullom SJ: Principles of Cardiac SPECT. In: Cardiac SPECT Imaging (De Puey EG, Garcia EV, Berman DS, eds). Philadelphia: Lippincott, Williams and Wilkins, 2001; pp6-14.
22. McCullagh P, Nelder JA: Generalized Linear Models. Second Edition Series Monographs on Statistics and Applied Probability. Cambridge: University Press, 1966.
23. Charvat J, Michalova K, Taborska K, Chlumsky J, Kvapil M: Comparison of the exercise ECG and stress myocardial SPECT in detection of the significant coronary artery disease in the asymptomatic patients with diabetes mellitus type 2. Bratisl Lek Listy 2004; 105: 56-61.
24. Niskanen LK, Penttila I, Parviainen M, Uusitupa MI: Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care 1996; 19: 486-493.
25. Rutter MK, McComb JM, Brady S, Marshall SM: Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus. Am J Cardiol 1999; 83: 27-31.
26. Bell DS: Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 1995; 18: 708-714.
27. Celik SK, Sagcan A, Buket S, Yuksel M, Kultursay H: Effects of coronary artery bypass surgery on diastolic and systolic parameters of left ventricle in Type II diabetic patients. J Diabetes Complications 2003; 17: 73-77.
28. Bhargava K, Hansa G, Bansal M, Tandon S, Kasliwal RR: Endothelium-dependent brachial artery flow mediated vasodilatation in patients with diabetes mellitus with and without coronary artery disease. J Assoc Physicians India 2003; 51: 355-358.
29. Nielsen FS, Rossing P, Gall MA, Smidt UM, Chen JW, Sato A, et al: Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. Scan J Clin Lab Invest 1997; 57: 427-434.
30. Meeking DR, Cummings MH, Thorne S, Donald A, Clarkson P, Crook JR: Endothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuria. Diabet Med 1999; 16: 841-847.